Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Dorsata

Explore full profile

Platform for the creation, distribution and implementation of clinical carepaths

Arlington, United StatesFounded 2011Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2020
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Dorsata and the history behind them.

About Dorsata

Dorsata is a healthcare technology company specializing in clinical decision support systems tailored for obstetrics and gynecology (OB-GYN) practices. The company operates in the healthcare technology market, serving medical professionals and healthcare providers who focus on women's health. Dorsata's core product, the ACOG Prenatal Record, integrates seamlessly with existing electronic health records (EHR) to provide real-time, evidence-based guidelines from the American College of Obstetricians and Gynecologists (ACOG). This system enhances the efficiency of OB-GYN workflows by automating routine tasks, improving diagnosis, treatment, and documentation processes. The platform is designed to be intuitive, requiring minimal training, and aims to maximize the time healthcare providers spend with patients while minimizing administrative overhead. Dorsata generates revenue through a subscription-based business model, charging healthcare providers for access to its advanced clinical decision support tools. The company also offers ancillary services and pathway guideline development to further support healthcare providers in delivering optimal patient care.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Arlington, United States
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning Dorsata.

See all news

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • Partnership Fund for New York City
  • Gore Range Capital
  • QED Investors
  • Motley Fool Ventures
  • 76 Forward

Series A2 investors entered at this stage

  • Dartmouth-Hitchcock Medical Center
  • LabCorp

Series B and later1 investor entered at this stage

  • Builders + Backers
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Dorsata on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Dorsata on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.